跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ AMBRISENTAN TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ AMBRISENTAN TABLETS
Authorized
STANDARD
SANDOZ AMBRISENTAN TABLETS
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e89ef3a3cc9697f5
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
e89ef3a3cc9697f5
Drug Approval Canada Name
SANDOZ AMBRISENTAN TABLETS
Product Name
SANDOZ AMBRISENTAN TABLETS
Status
Marketed
Status Date
2022-10-07
Original Market Date
2022-10-07
Din
02526883
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:48.00
Atc Original
C02KX02 AMBRISENTAN
Atc Name
c 02 kx 02
Aig Number
0152452002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
AMBRISENTAN
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e89ef3a3cc9697f5
Type
Standard
Back to Health Canada Approvals